355391-05-8 Usage
Description
4-(cyclopropylmethoxy)benzoic acid is a chemical compound with a molecular formula C11H12O3, belonging to the benzoic acid family and featuring a cyclopropylmethoxy functional group. It is a versatile compound with potential applications in various fields due to its unique structure and properties.
Uses
Used in Pharmaceutical Industry:
4-(cyclopropylmethoxy)benzoic acid is used as an intermediate in the synthesis of various drugs and active pharmaceutical ingredients, contributing to the development of new medications and therapies.
Used in Anti-inflammatory Applications:
4-(cyclopropylmethoxy)benzoic acid is studied for its potential anti-inflammatory properties, which could be utilized in the treatment of inflammation-related conditions and diseases.
Used in Antibacterial Applications:
4-(cyclopropylmethoxy)benzoic acid is also investigated for its potential antibacterial properties, which could be employed in the development of new antibiotics to combat bacterial infections.
Used in Disease Treatment Research:
4-(cyclopropylmethoxy)benzoic acid has been explored for its potential role in the treatment of various diseases and conditions, making it a compound of interest for further research and development in the medical field.
Check Digit Verification of cas no
The CAS Registry Mumber 355391-05-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,5,3,9 and 1 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 355391-05:
(8*3)+(7*5)+(6*5)+(5*3)+(4*9)+(3*1)+(2*0)+(1*5)=148
148 % 10 = 8
So 355391-05-8 is a valid CAS Registry Number.
355391-05-8Relevant articles and documents
Stepwise benzylic oxygenation via uranyl-photocatalysis
Hu, Deqing,Jiang, Xuefeng
supporting information, p. 124 - 129 (2022/01/19)
Stepwise oxygenation at the benzylic position (1°, 2°, 3°) of aromatic molecules was comprehensively established under ambient conditions via uranyl photocatalysis to produce carboxylic acids, ketones, and alcohols, respectively. The accuracy of the stepwise oxygenation was ensured by the tunability of catalytic activity in uranyl photocatalysis, which was adjusted by solvents and additives demonstrated through Stern–Volmer analysis. Hydrogen atom transfer between the benzylic position and the uranyl catalyst facilitated oxygenation, further confirmed by kinetic studies. Considerably improved efficiency of flow operation demonstrated the potential for industrial synthetic application.
COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
-
Page/Page column 155; 156, (2017/03/14)
The present invention relates to the use of piperazinones for inhibiting arenavirus infection in humans, other mammals, or in cell culture, to methods of treating arenavirus infection such as Lassa, Bolivian, Argentine, Venezuelan, Brazilian, Chapare and
8-benzamidochromen-4-one-2-carboxylic acids: Potent and selective agonists for the orphan G protein-coupled receptor GPR35
Funke, Mario,Thimm, Dominik,Schiedel, Anke C.,Müller, Christa E.
, p. 5182 - 5197 (2013/07/25)
8-Amido-chromen-4-one-2-carboxylic acid derivatives were identified as novel agonists at the G protein-coupled orphan receptor GPR35. They were characterized by a β-arrestin recruitment assay and optimized to obtain agonists with nanomolar potency for the
